Q1 Sales Up 9.6% and All Three Segments Profitable; FY27 EBITDA Guidance Raised
LUXE sits 71% above its 52-week low of $6.54 on elevated volume (2.1× avg).
Summary
LuxExperience posted Q1 FY27 net sales of €610.5 million, up 9.6% reported and 8.5% ex-FX, with Adjusted EBITDA of €12.7 million (2.1% margin) versus a €18.2 million loss a year ago — the fourth straight quarter of positive Adjusted EBITDA. All three segments improved: Mytheresa Adjusted EBITDA more than doubled to €17.9 million on 10.8% sales growth, NAP & MRP swung to a €0.7 million profit with US sales up 26.4% reported, and YOOX more than halved its loss to €6.0 million. Management raised FY27 Adjusted EBITDA margin guidance to 2.5%-3.5% from 2%-3% and narrowed net sales growth to +6% to +9%. The quarter also showed group Adjusted SG&A down 11.1%, a net loss from continuing operations narrowing to €34.1 million from €87.7 million, and a loss per share of EUR0.24. This follows the Q4 FY26 report in September that first showed NAP & MRP turning positive, and comes after the FY2026 20-F disclosed material weaknesses in internal controls — a lingering overhang. The 8:00am ET call today will be the first chance to press management on guidance durability and the control remediation.
At the time of this announcement, LUXE was trading at $11.19 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $6.54 to $11.38. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: BusinessWire.